Clincosm LogoSign in Get a demo

ovarian cancer

Showing NaN - NaN of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)

Not yet recruiting
  • Ovarian Cancer
  • Lung Adenocarcinoma
  • Duarte, California
  • +6 more
Mar 21, 2023

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Breast Cancer, Ovarian Cancer, Pancreatic Cancer Trial in United States (Standard Genetic Counseling, Educational Video)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Standard Genetic Counseling
  • Educational Video
  • Boston, Massachusetts
  • +5 more
Jan 25, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Ovarian Cancer Trial in Worldwide (AZD2281, matching )

Active, not recruiting
Has Results
  • Ovarian Cancer
  • Berkeley, California
  • +73 more
Dec 19, 2022

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Ovarian Cancer Trial in Boston (Zafirlukast)

Recruiting
  • Ovarian Cancer
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 11, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (Paclitaxel, Carboplatin, Atezolizumab)

Completed
  • Ovarian Cancer
  • +2 more
  • Phoenix, Arizona
  • +267 more
Nov 7, 2022

Genetic Testing, Breast Cancer, Ovarian Cancer Trial in Boston (Video Education, Genetic Counseling)

Recruiting
  • Genetic Testing
  • +8 more
  • Video Education
  • Genetic Counseling
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 31, 2022

Ovarian Cancer Trial in Boston (Enoxaparin, Enoxaparin + Rosuvastatin, Thromboprophylaxis)

Active, not recruiting
  • Ovarian Cancer
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (REGN5668, Cemiplimab, REGN4018)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +7 more
Sep 26, 2022

Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)

Recruiting
  • Advanced Cancer
  • +7 more
  • Scottsdale, Arizona
  • +14 more
Sep 15, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

Recruiting
  • Advanced Solid Tumor Historically Known for High EphA2 Expression
  • +6 more
  • Encinitas, California
  • +27 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022